Zacks Research Issues Positive Forecast for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Research analysts at Zacks Research lifted their Q2 2026 earnings per share estimates for Phibro Animal Health in a report issued on Tuesday, January 7th. Zacks Research analyst R. Department now expects that the company will earn $0.49 per share for the quarter, up from their prior forecast of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2026 earnings at $0.36 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $1.66 EPS and FY2027 earnings at $2.12 EPS.

A number of other equities research analysts have also recently weighed in on PAHC. Barclays boosted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, StockNews.com raised Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 4th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Down 6.7 %

Shares of NASDAQ:PAHC opened at $20.05 on Thursday. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The firm has a 50 day simple moving average of $22.75 and a 200-day simple moving average of $21.08. The company has a market capitalization of $812.09 million, a PE ratio of 46.63, a P/E/G ratio of 0.58 and a beta of 0.53. Phibro Animal Health has a twelve month low of $10.03 and a twelve month high of $25.98.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. nVerses Capital LLC purchased a new position in Phibro Animal Health in the 3rd quarter valued at $70,000. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health in the third quarter valued at about $70,000. China Universal Asset Management Co. Ltd. increased its stake in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the period. CWM LLC raised its holdings in Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after purchasing an additional 4,175 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in Phibro Animal Health in the 2nd quarter valued at approximately $193,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.39%. Phibro Animal Health’s payout ratio is 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.